Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;49(3):162-9.
doi: 10.1007/s11626-013-9588-2. Epub 2013 Feb 14.

Gastrin-induced proliferation involves MEK partner 1 (MP1)

Affiliations

Gastrin-induced proliferation involves MEK partner 1 (MP1)

Tonje S Steigedal et al. In Vitro Cell Dev Biol Anim. 2013 Mar.

Abstract

The peptide hormone gastrin is an important factor for the maintenance and homeostasis of the gastric mucosa. We show that gastrin stimulates proliferation in a dose-dependent manner in the human gastric adenocarcinoma cell line AGS-GR. Furthermore, we demonstrate that the MAPK scaffold protein MEK partner 1 (MP1) is important for gastrin-induced phosphorylation of ERK1 and ERK2 and that MP1 promotes gastrin-induced proliferation of AGS-GR cells. Our results suggest a role of MP1 in gastrin-induced cellular responses involved in proliferation and homeostasis of the gastric mucosa.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
xCELLigence proliferation assay of wild-type AGS and AGS-GR cells in response to gastrin. AGS and AGS-GR cells were seeded in 96-well E-plates for xCELLigence assay monitoring impedance (cell index). The cells were treated with either 10% FCS or 100 ng/ml EGF as controls or gastrin at different concentrations (0.1, 1, 10, or 100 nM) in either absence or presence of serum. (a) Complete growth curves of AGS and AGS-GR cells from 0 to 70 h after seeding. The cells were treated with gastrin and EGF in absence of serum. Panel to the right shows bar graph of cell index at 24 h growth. (b) Complete growth curves of AGS and AGS-GR cells from 0 to 70 h after seeding. The cells were treated with gastrin and EGF in presence of serum. Panel to the right shows bar graph of cell index at 24 h growth. Data is represented as mean ± SD of three independent experiments.
Figure 2.
Figure 2.
Gastrin-mediated activation of MP1 in AR42J and AGS-GR cells. (a) Verification of gene expression microarray results with quantitative RT-PCR in AR42J. Cells were seeded in 6-well plates and serum starved for 24 h the following day prior to treatment with gastrin (10 nM) as indicated in figure. (b) Quantitative RT-PCR analysis of MP1 expression in AGS-GR. Cells were seeded in 6-well plates and cultivated 24 h prior to gastrin treatment (10 nM) as indicated in figure. Fold induction levels were calculated using the ΔΔCt-method (Livak and Schmittgen 2001), where the expression levels were normalized to the level of β-actin (AR42J) or GAPDH (AGS-GR) expression, and gastrin-treated cells were compared to untreated cells. One representative experiment is shown and data presented as mean ± SD of three technical replicates. (c) Western blot of AGS-GR lysates from cells treated with 10 nM of gastrin 2–10 h before harvesting. The blot was treated with non-commercial antibodies against MP1, and β-actin was used as loading control. Lower panels show relative quantification of band intensities from western blot analysis.
Figure 3.
Figure 3.
MP1 depletion reduces gastrin-induced phosphorylation of ERK1 and ERK2 (p-ERK1/2). (a) AGS-GR cells were transfected with siMP1 and siCtr for 24 h. Then, the cells were serum starved for 24 h and treated with 10 nM gastrin for 5 to 30 min before harvesting. Protein extracts were subjected to SDS-PAGE and analyzed for p-ERK1 and p-ERK2 in addition to GAPDH (loading control). (b, c) Densiometric analysis of relative amounts of p-ERK1 and p-ERK2, respectively. One representative experiment is shown. Similar results were obtained three times.
Figure 4.
Figure 4.
MP1 enhances cell cycle progression. AGS-GR cells were grown and treated with siCtr, siMP1, or siCycD1. Cells were treated with 10 nM gastrin without medium replacement 24 h after transfection and then grown for another 24 h. Finally, the cells were harvested in citrate buffer and treated with buffers A, B, and C according to a slightly modified version of the Vindelov protocol (Vindelov et al. 1983). The proportion of cells in S-phase of the cell cycle in untreated (black) and gastrin-treated (red) bars. DNA histograms were created from 20,000 propidium iodide stained nuclei. Representative histograms are shown, and data is presented as percent cells in S-phase mean ± SD (n = 3). Using qRT-PCR, MP1 depletion was found to be approximately 90% (data not shown).

Similar articles

Cited by

References

    1. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7:812–21. doi: 10.1101/gad.7.5.812. - DOI - PubMed
    1. Bestervelt L, Barr B, Dethloff L. Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells. Cell Signal. 2000;12:53–61. doi: 10.1016/S0898-6568(99)00067-4. - DOI - PubMed
    1. Detjen K, Fenrich MC, Logsdon CD. Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines. Gastroenterology. 1997a;112:952–9. doi: 10.1053/gast.1997.v112.pm9041258. - DOI - PubMed
    1. Detjen K, Yule D, Tseng MJ, Williams JA, Logsdon CD. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. Am J Physiol. 1997b;273:C1449–57. - PubMed
    1. Dimaline R, Varro A. Attack and defence in the gastric epithelium—a delicate balance. Exp Physiol. 2007;92:591–601. doi: 10.1113/expphysiol.2006.036483. - DOI - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources